PUBLIC COMPANY
save$ACETAdicet Bio, Inc.
$ACETBoston, MA, USupdated 21d ago
community read0 votes
pipeline
3
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(3)
pipeline depth3 products
1Preclinical1Phase 11Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- —Long-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T Cells
- phase1A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune Disease
- phase1A Phase 1 Study of ADI-001 in Rheumatoid Arthritis
- phase2A Phase 1/2 Trial of ADI-270 in ccRCC
- phase1A Phase 1 Study of ADI-001 in B Cell Malignancies
Insider activity
source: SEC Form 4open-market buys + sells
routine RSU / option mechanics (5)
- Mar 25, 26grantHealey Don · Chief Technology Officer43,361 sh
- Mar 25, 26grantAftab Blake · Chief Scientific Officer72,555 sh
- Mar 25, 26grantHarvey Brian Nicholas · Chief Financial Officer43,361 sh
- Mar 25, 26grantSchor Chen · President & CEO468,555 sh
- Mar 25, 26grantMaltzman Julia D. · Chief Medical Officer72,555 sh
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 3m ago
Found something off?
comments(0)
5-min edit window · permanent after that